Naixi Wu reports multiple 10b5-1 stock sales
Naixi Wu reported multiple sales of Common Stock under Rule 144/10b5-1 plans.
Rhea-AI Filing Summary
Naixi Wu reported multiple sales of Common Stock under Rule 144/10b5-1 plans. The filing lists sales on 04/06/2026 (5,876 shares, $17,547.50), 04/09/2026 (55,000 shares, $154,561.00), 06/01/2026 (6,000 shares, $29,662.80), and 06/02/2026 (12,898 shares, $65,997.78). The transactions are identified as 10b5-1 sales and appear as routine dispositions reported on the notice form.
Positive
- None.
Negative
- None.
Insights
Multiple scheduled 10b5-1 sales reported by Naixi Wu across April–June 2026.
These entries list specific share counts and proceeds: $17,547.50 for 5,876 shares on 04/06/2026, $154,561.00 for 55,000 shares on 04/09/2026, $29,662.80 for 6,000 shares on 06/01/2026, and $65,997.78 for 12,898 shares on 06/02/2026. The filings label these as 10b5-1 sales, indicating pre-arranged trading plans.
The practical implication is procedural: these are reported dispositions under a trading plan rather than discretionary open-market trades. Cash‑flow treatment and any remaining holdings after these transactions are not detailed in the provided excerpt; subsequent filings would show post-transaction positions if reported.
Key Figures
Key Terms
10b5-1 regulatory
Form 144 regulatory
Restricted Stock Awards financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Naixi Wu report in the Form 144 for INDI?
Were the sales reported by Naixi Wu made under a trading plan?
Does the Form 144 excerpt show proceeds received from these sales?
Who is the reporting person and what security was sold?
AI-generated analysis. How Rhea-AI works. Not financial advice.